Cancer - Cancer PHGKB -

Genomics and Precision Health Weekly Update | CDC

Cancer

- Cancer PHGKB -

What's New

Last Posted: May 30, 2020

---

• Engaging Men With BRCA-Related Cancer Risks: Practical Advice for BRCA Risk Management From Male Stakeholders 
  M Dean et al, AM J Men's Health, May 25, 2020
• How can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens 
  R O'Shea et al, Genetics in Medicine, May 28, 2020
• Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes 
  T Frebourg et al, EJHG et al, May 26, 2020
• Liquid biopsy for early stage lung cancer moves ever closer 
  C Rolfo et al, Nat Rev Clin Oncol, May 26, 2020
• Genomics-guided pre-clinical development of cancer therapies 
  HE Francies et al, Nature Cancer, May 2020
• Local cellular cues that influence the immunology of colorectal cancer treatment 
  GP Donaldson et al, Nature Medicine, May 25, 2020
• Diagnosing hereditary cancer predisposition in men with prostate cancer. 
  Pritzlaff Mary et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 May
• MHC-I genotype and tumor mutational burden predict response to immunotherapy 
  AM Goodman et al, Genome Medicine, May 19, 2020
• Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses 
  H Zhang et al, Nature Genetics, May 18, 2020
• Microbial DNA signature in plasma enables cancer diagnosis 
  A Dzutsev et al, Nat Rev Clin Oncology, May 2020
• Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer 
  P Butow et al, JAMA Network Open, May 14, 2020
• Clinical Application of Computational Methods in Precision Oncology- A Review 
  OA Panagiotou et al, JAMA Oncology, May 14, 2020
• Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden. 
  Qing Tao et al. Nature communications 2020 May (1) 2438
• Future directions for implementation science at the National Cancer Institute: Implementation Science Centers in Cancer Control. 
  Oh April et al. Translational behavioral medicine 2020 Mar
• Immune-related adverse events of checkpoint inhibitors 
  MR Casals et al, Nature Rev did Primers